,
,
,
,
,
,
,
,
,
,
,
,
,
31 La protéine MCM6 (MiniChromosome Maintenance protein 6) ,
,
,
,
,
,
,
,
,
,
,
45 MCM6 and Ki-67 protein expressions in endometrial adenocarcinoma ,
47 Prognostic value of levels of Ki-67 and MCM6 mRNA in TCGA database and correlation with molecular features ,
49 Clinico-pathological prognostic factors in endometrioid type endometrial neoplasm ,
, CENP-A containing chromatin organization (p=2.48E-9, pp.94-105
Cancer statistics, CA Cancer J Clin, vol.66, pp.7-30, 2016. ,
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012, Eur J Cancer Oxf Engl, vol.49, pp.1374-1403, 1990. ,
Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study, J Clin Oncol Off J Am Soc Clin Oncol, vol.22, pp.2159-2166, 2004. ,
Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study, 2004. ,
, J Clin Oncol Off J Am Soc Clin Oncol, vol.22, pp.3902-3908
Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system, Eur J Obstet Gynecol Reprod Biol, vol.143, pp.69-74, 2009. ,
Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas, Clin Cancer Res Off J Am Assoc Cancer Res, vol.4, pp.2779-2785, 1998. ,
Mechanisms restricting DNA replication to once per cell cycle: the role of Cdc6p and ORC, Trends Cell Biol, vol.7, pp.9-10, 1997. ,
Methyl(R217)HuR and MCM6 are inversely correlated and are prognostic markers in non small cell lung carcinoma, Lung Cancer Amst Neth, vol.89, pp.189-196, 2015. ,
Expression of minichromosome maintenance MCM6 protein in meningiomas is strongly correlated with histologic grade and clinical outcome, Am J Surg Pathol, vol.36, pp.283-291, 2012. ,
Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors, Int J Gynecol Pathol Off J Int Soc Gynecol Pathol, vol.22, pp.334-340, 2003. ,
Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis, Gynecol Obstet Invest, vol.46, pp.307-313, 2005. ,
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up, Int J Gynecol Cancer Off J Int Gynecol Cancer Soc, vol.26, 2016. ,
Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group, Ann Surg Oncol, vol.24, pp.1660-1666, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01543368
Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level, Int J Gynecol Pathol Off J Int Soc Gynecol Pathol, vol.23, pp.129-137, 2004. ,
Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?, Am J Surg Pathol, vol.36, pp.753-761, 2012. ,
, Int J Gynecol Pathol Off J Int Soc Gynecol Pathol, vol.22, pp.141-148
Relationship between PTEN, DNA mismatch repair, and tumor histotype in endometrial carcinoma: retained positive expression of PTEN preferentially identifies sporadic non, 2013. ,
, Mod Pathol Off J U S Can Acad Pathol Inc, vol.26, pp.1401-1412
The p53 tumour suppressor gene, Nature, vol.351, pp.453-456, 1991. ,
TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers, Int J Gynecol Pathol Off J Int Soc Gynecol Pathol, vol.35, pp.289-300, 2016. ,
p53 overexpression in advanced-stage endometrial adenocarcinoma, Am J Obstet Gynecol, vol.175, pp.1246-1252, 1996. ,
) p53 protein overexpression in early stage endometrial cancer, Gynecol Oncol, vol.62, pp.213-217, 1996. ,
overexpression as a prognostic indicator in endometrial carcinoma, Eur J Gynaecol Oncol, vol.24, pp.275-278, 2003. ,
Prognostic importance of selected molecular immunohistochemical markers and DNA ploidy in endometrial cancer, Eur J Gynaecol Oncol, vol.33, pp.159-163, 2012. ,
Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer, Nat Genet, vol.17, pp.271-272, 1997. ,
Mutations of two PMS homologues in hereditary nonpolyposis colon cancer, Nature, vol.371, pp.75-80, 1994. ,
Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators, Am J Surg Pathol, vol.31, pp.309-314, 2007. ,
,
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012, Eur J Cancer Oxf Engl, vol.49, issue.6, pp.1374-403, 1990. ,
Clinical manifestations and treatment of dysfunctional uterine bleeding, JAMA, vol.269, issue.14, pp.1823-1831, 1993. ,
Cancer statistics, CA Cancer J Clin, vol.66, issue.1, pp.7-30, 2016. ,
Projection de l'incidence et de la mortalité par cancer en France métropolitaine en 2015, 2015. ,
Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer, Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet, vol.95, issue.1, pp.105-148, 2006. ,
Histological and immunohistochemical profiles predict lymph node status in women with lowintermediate risk endometrial cancer, Gynecol Oncol, vol.130, issue.3, pp.457-62, 2013. ,
Contribution of immunohistochemical profile in assessing histological grade of endometrial cancer, Anticancer Res, vol.33, issue.5, pp.2191-2199, 2013. ,
,
,
Relationship between Quetelet's index and cancer of breast and female genital tract in 47,000 women followed for 25 years, Br J Cancer, vol.69, issue.2, pp.358-61, 1994. ,
Diabetes and endometrial cancer: an Italian case-control study, Int J Cancer, vol.81, issue.4, pp.539-581, 1999. ,
Hypertension and hormone-related neoplasms in women. Hypertens Dallas Tex, 1979. ,
Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study, Am J Obstet Gynecol, vol.167, issue.5, pp.1317-1342, 1992. ,
Tamoxifen therapy for breast cancer and endometrial cancer risk, J Natl Cancer Inst, vol.91, pp.1654-62, 1999. ,
Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer, Clin Cancer Res Off J Am Assoc Cancer Res, vol.11, issue.18, pp.6422-6452, 2005. ,
Family history and risk of endometrial cancer: a systematic review and meta-analysis, Obstet Gynecol, vol.125, issue.1, pp.89-98, 2015. ,
Cancer incidence and mortality in France over the period 1978-2000. Rev Dépidémiologie Santé Publique, vol.51, pp.3-30, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-00427472
Recommandations pour la pratique clinique-Cancer de l'endomètre, 2010. ,
Accuracy of preoperative endometrial sampling diagnosis for predicting the final pathology grading in uterine endometrioid carcinoma, Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol, vol.42, issue.9, pp.1367-71, 2016. ,
Evaluation of the woman with postmenopausal bleeding: Society of Radiologists in Ultrasound-Sponsored Consensus Conference statement, J Ultrasound Med Off J Am Inst Ultrasound Med, vol.20, issue.10, pp.1025-1061, 2001. ,
The role of transvaginal sonography and endometrial biopsy in the evaluation of peri-and postmenopausal bleeding, AJR Am J Roentgenol, vol.169, issue.1, pp.145-154, 1997. ,
Endometrial cancer-revisiting the importance of pelvic and para aortic lymph nodes, Gynecol Oncol, vol.104, issue.1, pp.222-253, 2007. ,
Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system, Eur J Obstet Gynecol Reprod Biol, vol.143, issue.2, pp.69-74, 2009. ,
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up, Int J Gynecol Cancer Off J Int Gynecol Cancer Soc, 2016. ,
Integrated genomic characterization of endometrial carcinoma, Nature, vol.497, pp.67-73, 2013. ,
Follow-up after primary therapy for endometrial cancer: a systematic review, Gynecol Oncol, vol.101, issue.3, pp.520-529, 2006. ,
Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer, Int J Gynecol Cancer Off J Int Gynecol Cancer Soc, vol.25, issue.8, pp.1437-1481, 2015. ,
Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation, Int J Cancer, vol.31, issue.1, pp.13-20, 1983. ,
Molecular characterization of the gene locus of the human cell proliferation-associated nuclear protein defined by monoclonal antibody Ki-67, Cell Prolif, vol.29, issue.1, pp.1-12, 1996. ,
Ki-67 expression during rat liver regeneration after partial hepatectomy. Hepatol Baltim Md, vol.26, pp.573-581, 1997. ,
Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells, Cell Prolif, vol.25, issue.1, pp.31-40, 1992. ,
Ki-67 labeling in postmitotic cells defines different Ki-67 pathways within the 2c compartment, Cytometry, vol.12, issue.5, pp.455-63, 1991. ,
Retrospective analysis of risk factors for central nervous system metastases in operable breast cancer: effects of biologic subtype and Ki67 overexpression on survival, Oncology, vol.84, issue.3, pp.135-175, 2013. ,
Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas, PloS One, vol.7, issue.10, p.47068, 2012. ,
Prognostic value of p53 and Ki67 expression in fiberoptic bronchial biopsies of patients with non small cell lung cancer, Multidiscip Respir Med, vol.7, issue.1, p.29, 2012. ,
Biology and treatment of metastatic gastrointestinal neuroendocrine tumors. Gastrointest Cancer Res GCR, vol.2, pp.113-138, 2008. ,
Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas, Clin Cancer Res Off J Am Assoc Cancer Res, vol.4, issue.11, pp.2779-85, 1998. ,
Prognostic significance of angiogenesis and Ki67, p53, and p21 expression: a population-based endometrial carcinoma study, J Clin Oncol Off J Am Soc Clin Oncol, vol.17, issue.5, pp.1382-90, 1999. ,
Expression of Ki-67 as proliferation biomarker in imprint smears of endometrial carcinoma, Diagn Cytopathol, vol.41, issue.3, pp.212-219, 2013. ,
A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma, Gynecol Oncol, vol.93, issue.1, pp.34-40, 2004. ,
Steroid receptors, HER2/neu and Ki-67, in endometrioid type of endometrial carcinoma: Correlation with conventional histomorphological features of prognosis, Acta Histochem, vol.112, issue.4, pp.355-63, 2010. ,
MCM proteins in DNA replication, Annu Rev Biochem, vol.68, pp.649-86, 1999. ,
DNA replication in eukaryotic cells, Annu Rev Biochem, vol.71, pp.333-74, 2002. ,
Purification of an MCM-containing complex as a component of the DNA replication licensing system, Nature, vol.375, issue.6530, pp.418-439, 1995. ,
Identification of the yeast MCM3-related protein as a component of Xenopus DNA replication licensing factor, Cell, vol.81, issue.4, pp.601-610, 1995. ,
Loading of an Mcm protein onto DNA replication origins is regulated by Cdc6p and CDKs, Cell, vol.90, issue.4, pp.649-60, 1997. ,
Uninterrupted MCM2-7 function required for DNA replication fork progression, Science, vol.288, issue.5471, pp.1643-1650, 2000. ,
Isolation and characterization of various complexes of the minichromosome maintenance proteins of Schizosaccharomyces pombe, J Biol Chem, vol.275, issue.25, pp.18871-18879, 2000. ,
Biochemical analysis of the intrinsic Mcm4-Mcm6mcm7 DNA helicase activity, Mol Cell Biol, vol.19, issue.12, pp.8003-8018, 1999. ,
Immunolocalization of hCDC47 protein in normal and neoplastic human tissues and its relation to growth, Int J Cancer, vol.74, issue.2, pp.180-184, 1997. ,
Specific distribution patterns of hCDC47 expression in cutaneous diseases, J Cutan Pathol, 1998. ,
Characterisation of a human homologue of a yeast cell division cycle gene, MCM6, located adjacent to the 5' end of the lactase gene on chromosome 2q21, FEBS Lett, vol.398, issue.23, pp.135-175, 1996. ,
The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle, J Pathol, vol.190, issue.5, pp.537-581, 2000. ,
The Mcm complex: unwinding the mechanism of a replicative helicase, Microbiol Mol Biol Rev MMBR, vol.73, issue.4, pp.652-83, 2009. ,
Expression of minichromosome maintenance MCM6 protein in meningiomas is strongly correlated with histologic grade and clinical outcome, Am J Surg Pathol, vol.36, issue.2, pp.283-91, 2012. ,
Methyl(R217)HuR and MCM6 are inversely correlated and are prognostic markers in non small cell lung carcinoma, Lung Cancer Amst Neth, vol.89, issue.2, pp.189-96, 2015. ,
Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis, Histopathology, vol.46, issue.3, pp.307-320, 2005. ,
Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors, Int J Gynecol Pathol Off J Int Soc Gynecol Pathol, vol.22, issue.4, pp.334-374, 2003. ,
The Cancer Genome Atlas (TCGA) Data Portal Use Case Workshop, 2008. ,
Endometrial cancer, Obstet Gynecol, vol.111, pp.436-447, 2008. ,
, , 2003.
, Gynecol Obstet Fertil, vol.31, pp.581-596
Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences, Am J Surg Pathol, vol.31, pp.979-987, 2007. ,
Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial, J Pathol, vol.198, issue.3, pp.292-301, 2002. ,
Ki-67 detects a nuclear matrix-associated proliferation-related antigen. II. Localization in mitotic cells and association with chromosomes, J Cell Sci, vol.92, pp.531-571, 1989. ,
Immunohistochemical estimation of cell cycle phase in laryngeal neoplasia, Br J Cancer, vol.95, issue.3, pp.314-335, 2006. ,
A novel immunohistochemical method to estimate cell-cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer, J Pathol, vol.201, issue.2, pp.187-97, 2003. ,
Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells, Exp Cell Res, vol.309, issue.1, pp.56-67, 2005. ,
DNA replication licensing in somatic and germ cells, J Cell Sci, vol.117, pp.5875-86, 2004. ,
The p53 tumour suppressor gene, Nature, vol.351, pp.453-456, 1991. ,
TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers, Int J Gynecol Pathol Off J Int Soc Gynecol Pathol, vol.35, pp.289-300, 2016. ,
p53 overexpression in advanced-stage endometrial adenocarcinoma, Am J Obstet Gynecol, vol.175, pp.1246-1252, 1996. ,
) p53 protein overexpression in early stage endometrial cancer, Gynecol Oncol, vol.62, pp.213-217, 1996. ,
overexpression as a prognostic indicator in endometrial carcinoma, Eur J Gynaecol Oncol, vol.24, pp.275-278, 2003. ,
Prognostic importance of selected molecular immunohistochemical markers and DNA ploidy in endometrial cancer, Eur J Gynaecol Oncol, vol.33, pp.159-163, 2012. ,
Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer, Nat Genet, vol.17, pp.271-272, 1997. ,
Mutations of two PMS homologues in hereditary nonpolyposis colon cancer, Nature, vol.371, pp.75-80, 1994. ,
Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators, Am J Surg Pathol, vol.31, pp.846-853, 2007. ,
DOI : 10.1097/01.pas.0000213423.30880.ac
MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome, Gynecol Oncol, vol.131, pp.309-314, 2013. ,
DOI : 10.1016/j.ygyno.2013.08.003
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium, Nat Genet, vol.25, pp.25-29, 2000. ,
) après déshydratation par des bains successifs d'éthanol à 70°, pp.96-100 ,